| Changes in the incidence of childhood obesity SA Cunningham, ST Hardy, R Jones, C Ng, MR Kramer, KMV Narayan Pediatrics 150 (2), e2021053708, 2022 | 76 | 2022 |
| Biases in self-reported height and weight measurements and their effects on modeling health outcomes CD Ng SSM-population health 7, 100405, 2019 | 38 | 2019 |
| Beyond recent BMI: BMI exposure metrics and their relationship to health CD Ng, MR Elliott, F Riosmena, SA Cunningham SSM-Population Health 11, 100547, 2020 | 30 | 2020 |
| Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in US commercial claims data NJ Engmann, D Sheinson, K Bawa, CD Ng, G Pardo Journal of Managed Care & Specialty Pharmacy 27 (5), 639-649, 2021 | 27 | 2021 |
| In, out, and fluctuating: obesity from adolescence to adulthood CD Ng, SA Cunningham Annals of epidemiology 41, 14-20, 2020 | 27 | 2020 |
| Global analysis of overweight prevalence by level of human development CD Ng Journal of Global Health 5 (2), 2015 | 19 | 2015 |
| The impact of funding inpatient treatments for COVID-19 on health equity in the United States: a distributional cost-effectiveness analysis S Kowal, CD Ng, R Schuldt, D Sheinson, R Cookson Value in Health 26 (2), 216-225, 2023 | 17 | 2023 |
| The association between persistence and adherence to disease-modifying therapies and healthcare resource utilization and costs in patients with multiple sclerosis G Pardo, ED Pineda, CD Ng, D Sheinson, NG Bonine Journal of Health Economics and Outcomes Research 9 (1), 111, 2022 | 17 | 2022 |
| Further results on SD-prime labeling GC Lau, WC Shiu, HK Ng, CD Ng, P Jeyanthi JCMCC 98, 151-170, 2016 | 15 | 2016 |
| Adherence to and persistence with disease-modifying therapies for multiple sclerosis over 24 months: a retrospective claims analysis G Pardo, ED Pineda, CD Ng, KK Bawa, D Sheinson, NG Bonine Neurology and Therapy 11 (1), 337-351, 2022 | 13 | 2022 |
| Errors in body mass index from self-reported data by sex and across waves of Add Health CD Ng Annals of epidemiology 39, 21-25, 2019 | 12 | 2019 |
| Stratification of BMI categories among older adults within and across countries CD Ng Public health nutrition 23 (2), 254-263, 2020 | 10 | 2020 |
| Estimating the US baseline distribution of health inequalities across race, ethnicity, and geography for equity-informative cost-effectiveness analysis S Kowal, CD Ng, R Schuldt, D Sheinson, K Jinnett, A Basu Value in Health 26 (10), 1485-1493, 2023 | 9 | 2023 |
| Association of genetic and behavioral characteristics with the onset of diabetes CD Ng, J Weiss BMC Public Health 19, 1-9, 2019 | 4 | 2019 |
| Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs) AM Zeidan, ES Mearns, CD Ng, A Shah, N Lamarre, A Yellow-Duke, ... Clinical Lymphoma Myeloma and Leukemia 24 (3), 177-186, 2024 | 2 | 2024 |
| From birth to adulthood: anthropometric trajectories and their implications for chronic diseases in Guatemala CD Ng Journal of biosocial science 51 (2), 292-306, 2019 | 2 | 2019 |
| US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma M Matasar, A Masaquel, R S. Ho, A Launonen, CD Ng, R Wang, D Fox, ... Journal of Medical Economics 26 (1), 1134-1144, 2023 | 1 | 2023 |
| Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone JM Burke, A Masaquel, R Wang, F Hossain, J Li, SQ Zhou, CD Ng, ... Clinical Lymphoma Myeloma and Leukemia 23 (11), e393-e404, 2023 | 1 | 2023 |
| Alzheimer’s Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab H Fillit, SS Assunção, T Majda, CD Ng, TM To, IM Abbass, K Raimundo, ... The Journal of Prevention of Alzheimer's Disease, 1-9, 2024 | | 2024 |
| Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA S Ailawadhi, A Ravelo, CD Ng, B Shah, N Lamarre, R Wang, K Eakle, ... Journal of Comparative Effectiveness Research 13 (2), e230119, 2024 | | 2024 |
